Bajaj Healthcare IPO is a Fixed Price listing on BSE SME exchange, with an ipo size of ₹ 30.90 Cr. The company is based in Boisar and caters to Pharmaceutical sector. Aryaman Financial Services is the merchant banker of Bajaj Healthcare IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 18th February 2016.
Bajaj Healthcare IPO posted revenues of ₹ 230.03 crores and PAT of ₹ 8.60 crores in FY16 on annualised basis.Financial results of Bajaj Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | Dec-15 | FY15 | FY14 | FY13 | |
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 160.69 | 145.84 | 145.42 | 131.00 | |
Net Worth | 43.76 | 37.57 | 30.05 | 28.08 | |
Total Debt | 72.69 | 59.63 | 63.10 | 63.64 | |
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
172.49
229.99 |
218.30 | 204.90 | 170.77 | |
EBITDA
EBITDA on annualised basis |
21.56
28.75 |
28.75 | 19.41 | 12.89 | |
PAT
PAT on annualised basis |
6.45
8.60 |
7.51 | 1.97 | -1.05 |
Bajaj Healthcare IPO PAT Margin is 3.74 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Bajaj Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | Dec-15 | FY15 | FY14 | FY13 |
---|---|---|---|---|
EBITDA Margin (%) | 12.50 | 13.17 | 9.47 | 7.55 |
PAT Margin (%) | 3.74 | 3.44 | 0.96 | -0.61 |
EPS (₹) | 9.56 | 11.13 | 2.92 | -1.56 |
ROE (%) | 14.74 | 19.99 | 6.56 | -3.74 |
ROCE (%) | [●] | [●] | [●] | [●] |
ROA (%) | 4.01 | 5.15 | 1.35 | -0.80 |
Debt to Equity | 1.66 | 1.59 | 2.10 | 2.27 |
The market Capitalisation of Bajaj Healthcare IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Bajaj Healthcare IPO prospectus highlights an Return on Equity (ROE) of 14.74 % , Return on Assets (ROA) of 4.01 %, and an EBITDA Margin of 12.50 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Bajaj Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Bajaj Healthcare IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Bajaj Healthcare IPO has a Price-to-Earnings (PE) ratio of 14.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Bajaj Healthcare IPO reported revenue of ₹ 230.03 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Bajaj Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Bajaj Healthcare recorded an EBITDA of ₹ 28.75 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Bajaj Healthcare Profit After Tax (PAT) is ₹ 8.60 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Bajaj Healthcare operates in Pharmaceutical and Manufacturing And Marketing Capabilities In Active Pharmaceutical. The Issue is listed on BSE SME in May, 2016. Bajaj Healthcare IPO size was 30.90 with Issue price of 170.00 .
Merchant Banker(s) of Bajaj Healthcare IPO: Aryaman Financial Services Limited
Bajaj Healthcare IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Bajaj Healthcare IPO listed at a listing price of 171.50 against the offer price of 170.00.
The current market price of Bajaj Healthcare is 504.85.
Why Us?